AI tools promise that anyone can build apps, so I put that claim to the test. After a few minor bumps, I built a custom ...

Episode 2 of the Peacock spy serial sets the stars up on a first date that includes strained banter, a bookstore visit and a ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...

Debate and discussion around data management, analytics, BI and information governance. This is a guest blog post by John Bates, CEO, SER, in which he reviews important new findings about what’s ...

Quantinuum has unveiled a third-generation quantum computer that could be easier to scale up than rival approaches. The US- and UK-based company Quantinuum today unveiled Helios, its third-generation ...

This has been a strong fantasy season so far for IDP owners. Most of the stars have looked like stars so far. We have seen a ton of huge performances with big plays and turnovers coming in bunches ...

London-based Quantum Motion Technologies Ltd. announced today it has delivered the industry’s first quantum computer built using traditional semiconductor chipmaking processes, the same technology ...

Microsoft's latest computing system uses micro-LEDs and camera sensors to perform calculations. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. A ...

A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from ...

CAMBRIDGE, U.K. – A small Microsoft Research team had lofty goals when it set out four years ago to create an analog optical computer that would use light as a medium for solving complex problems.

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Exact Sciences announced on Wednesday that it acquired the rights to a blood-based ...